查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363170

醫療設備給付市場規模、佔有率、趨勢分析報告：按付款人、醫療保健環境、地區和細分市場預測，2023-2030年

Medical Devices Reimbursement Market Size, Share & Trends Analysis Report By Payer (Public, Private), By Healthcare Setting (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 275 Pages | 商品交期: 2-10個工作天內

價格

醫療設備給付市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年全球醫療設備給付市場規模將達到1,0282億美元，2023年至2030年年複合成長率為8.8%。

醫療設備給付是指第三方私人或公共保險公司向醫療保健提供者支付的醫療設備使用過程中產生的費用。推動產業成長的關鍵因素是對給付的依賴增加，慢性病盛行率增加以及預防性醫療保健的擴大。對早期診斷和預防性護理的關注可能會活性化診斷設備行業的活動，推動更高的給付佔有率。

例如，透過醫療費用獎勵早期診斷（例如徹底的乳癌篩檢）的根本性範式轉變引起新興經濟體的關注。在COVID-19大流行期間，機器人輔助手術等手術推遲。然而，在大流行恢復期間，這些手術變得更加困難，特別是在亞太地區，因為日本和中國等國家積極參與向機器人輔助提供者提供給付，以提高手術精度，預計會有所改善。此類舉措可能會對疫情後的市場成長產生正面影響。隨著醫療設備需求的增加，給付服務可望為醫療保健產業帶來各種商機。此外，用戶的增加和醫療保健系統的整合是推動該行業成長的主要因素。

北美地區在2022年以超過 50.2%的收益佔有率佔據市場主導地位，預計在預測期內將保持其主導地位。對醫療設備的需求不斷成長以及醫療中心數量的增加預計將推動該地區的產業發展。慢性病的日益普及推動對各種醫療設備的需求。預計這將進一步支持該區域市場的成長。例如，2022年 1月發表在 Science Direct 上的一項研究發現，2011年至2021年間，影像影像檢查的醫療費用穩定下降。政府機構這種趨勢的持續預計將對疫情後的區域市場成長產生負面影響。

醫療設備給付市場報告亮點

  • 隨著眾多民營企業進入市場，民營支付機構佔據市場主導地位，2022年銷售佔有率將超過65.0%。
  • 從醫療保健環境來看，由於最近的技術發展以及大量患者需要使用醫療保健設備，醫院部門在2022年佔據了最大的收入佔有率，超過 51.8%。
  • 由於保險服務在農村和都市區的普及不斷提高，預計亞太地區在預測期內將快速成長。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 醫療設備給付市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 普及和成長前景圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 醫療設備給付市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 醫療設備給付：按支付方估算及趨勢分析

  • 醫療設備給付市場：要點
  • 醫療設備給付市場：2022年和2030年趨勢和市場佔有率分析
  • 公共
  • 私人

第5章 醫療設備給付：醫療環境測算及趨勢分析

  • 醫療設備給付市場：要點
  • 醫療設備給付市場：2022年和2030年趨勢和市場佔有率分析
  • 醫院
  • 門診設施
  • 其他

第6章 醫療設備給付市場：區域估計與趨勢分析

  • 區域展望
  • 依地區分類的醫療設備給付市場：要點
  • 北美洲
    • 2018-2030年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東、非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • UnitedHealth Group
    • Cigna
    • Humana Inc.
    • Allianz
    • Aviva
    • CVS Health
    • WellCare Health Plans
    • Nippon Life Insurance Company
    • BNP Paribas
    • Anthem Insurance Companies, Inc.
Product Code: GVR-4-68038-835-0

Medical Devices Reimbursement Market Growth & Trends:

The global medical devices reimbursement market size is expected to reach USD 1028.2 billion by 2030, expanding at a CAGR of 8.8% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Medical device reimbursement is defined as the payment a third-party private or public insurer pays a healthcare provider for the cost incurred while using medical equipment. The major factors fueling the industry growth are growing dependence on reimbursement, the increasing prevalence of chronic diseases, and growing preventive care. Focus on early diagnostics and preventive care may in turn lead to higher activity within the diagnostic device industry, thus promoting more reimbursement share from them.

For instance, a fundamental paradigm shift towards incentivizing early diagnosis through reimbursement has been noticed across developed economies, such as thorough screening for breast cancer. During the COVID-19 pandemic, surgeries such as robotic-assisted procedures were postponed. However, during the pandemic recovery period, these surgeries are expected to improve particularly in Asia pacific as the countries such as Japan and China are actively involved in providing reimbursement to robotic-assisted providers to improve the accuracy of surgeries. Such initiatives are likely to have a positive impact on market growth in the post-pandemic period. With an increasing demand for medical equipment, reimbursement services are expected to provide various opportunities for healthcare industries to poach upon. Additionally, the increasing number of people pursuing insurance and consolidation of the healthcare system are major factors fueling the industry growth.

North America dominated the market with a revenue share of over 50.2% in 2022 and is expected to maintain its dominance over the forecast period. The rising demand for healthcare equipment and the increasing number of healthcare centers are expected to drive the industry in this region. The growing prevalence of chronic diseases is driving the demand for various healthcare instruments. This is further expected to support the growth of the regional market. Over the years, the Centers for Medicare & Medicaid Services have reduced the reimbursement for diagnostic radiology in the U.S. For instance, in January 2022, a study published in Science Direct stated that, between 2011 - 2021, there was a steady decline in the reimbursement for diagnostic imaging studies. A continuation of this trend by the government agencies is expected to have a negative impact on the regional market growth in the post-pandemic period.

Medical Devices Reimbursement Market Report Highlights:

  • The private payer segment dominated the market with a revenue share of over 65.0% in 2022 due to the presence of a large number of private players
  • By healthcare setting, the hospitals segment held the largest revenue share of over 51.8% in 2022 due to recent technological developments and high patient footfall requiring the use of healthcare instruments
  • Asia Pacific is projected to witness rapid growth during the forecast period owing to the rising penetration of insurance services in rural and urban areas

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Payer
    • 1.1.2. Healthcare Setting
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Payer outlook
    • 2.2.2. Healthcare Setting outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Medical Device Reimbursement Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Medical Device Reimbursement Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic Landscape

Chapter 4. Medical Device Reimbursement: Payer Estimates & Trend Analysis

  • 4.1. Medical Device Reimbursement Market: Key Takeaways
  • 4.2. Medical Device Reimbursement Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Public
    • 4.3.1. Public market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Private
    • 4.4.1. Private market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Medical Device Reimbursement: Healthcare Setting Estimates & Trend Analysis

  • 5.1. Medical Device Reimbursement Market: Key Takeaways
  • 5.2. Medical Device Reimbursement Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hospitals
    • 5.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Outpatient facilities
    • 5.4.1. Outpatient facilities market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Medical Device Reimbursement Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Medical Device Reimbursement Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. UnitedHealth Group
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Cigna
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Humana Inc.
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Allianz
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Aviva
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. CVS Health
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. WellCare Health Plans
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Nippon Life Insurance Company
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. BNP Paribas
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Anthem Insurance Companies, Inc.
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 3 North America medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 4 North America medical device reimbursement market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 6 U.S. medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 7 Canada medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 8 Canada medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 9 Europe medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 10 Europe medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 11 Europe medical device reimbursement market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 13 Germany medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 14 UK medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 15 UK medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 16 France medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 17 France medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 18 Italy medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 19 Italy medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 20 Spain medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 21 Spain medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 22 Sweden medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 23 Sweden medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 24 Norway medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 25 Norway medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 26 Denmark medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 27 Denmark medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific medical device reimbursement market, by region, 2018 - 2030 (USD Million)
  • Table 31 China medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 32 China medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 33 Japan medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 34 Japan medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 35 India medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 36 India medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 37 Australia medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 38 Australia medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 39 Thailand medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 40 Thailand medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 41 South Korea medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 42 South Korea medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 43 Latin America medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 44 Latin America medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 45 Latin America medical device reimbursement market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 47 Brazil medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 48 Mexico medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 49 Mexico medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 50 Mexico medical device reimbursement market, by application, 2018 - 2030 (USD Million)
  • Table 51 Argentina medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 52 Argentina medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 55 Middle East and Africa medical device reimbursement market, by region, 2018 - 2030 (USD Million)
  • Table 56 South Africa medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 57 South Africa medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 60 UAE medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 61 UAE medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 62 Kuwait medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 63 Kuwait medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Medical device reimbursement: Market outlook
  • Fig. 9 Medical device reimbursement: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Medical device reimbursement market driver impact
  • Fig. 15 Medical device reimbursement market restraint impact
  • Fig. 16 Medical device reimbursement market strategic initiatives analysis
  • Fig. 17 Medical device reimbursement market: Payer movement analysis
  • Fig. 18 Medical device reimbursement market: Payer outlook and key takeaways
  • Fig. 19 Public market estimates and forecasts, 2018 - 2030
  • Fig. 20 Private market estimates and forecasts, 2018 - 2030
  • Fig. 21 Medical device reimbursement market: Healthcare setting movement analysis
  • Fig. 22 Medical device reimbursement market: Healthcare setting outlook and key takeaways
  • Fig. 23 Hospital market estimates and forecasts, 2018 - 2030
  • Fig. 24 Outpatient facilities market estimates and forecasts, 2018 - 2030
  • Fig. 25 Other market estimates and forecasts, 2018 - 2030
  • Fig. 26 Global medical device reimbursement market: Regional movement analysis
  • Fig. 27 Global medical device reimbursement market: Regional outlook and key takeaways
  • Fig. 28 North America market estimates and forecasts, 2018 - 2030
  • Fig. 29 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 30 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 31 Europe. market estimates and forecasts, 2018 - 2030
  • Fig. 32 UK market estimates and forecasts, 2018 - 2030
  • Fig. 33 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 34 France market estimates and forecasts, 2018 - 2030
  • Fig. 35 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 36 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 37 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 38 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 39 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 40 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 41 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 42 China market estimates and forecasts, 2018 - 2030
  • Fig. 43 India market estimates and forecasts, 2018 - 2030
  • Fig. 44 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 45 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 46 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 47 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 48 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 49 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 50 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 51 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 52 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 53 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 54 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 55 Kuwait market estimates and forecasts, 2018 - 2030